Trim 30-35% at $163-165 zone; hard stop at $152.88; re-engage after Q4 FY26 print
Underweight is the correct posture: valuation is stretched at ~25x forward P/E (vs 18-22x historical industrial range), technical extension shows exhaustion signatures (21% in 22 sessions, $18.58 above 50 SMA, MACD flattening, declining volume on advance), and risk/reward cuts the wrong way ($175 bull target = 7% upside vs $145.22 50 SMA = 11.4% downside, a 1:1.7 downside-to-upside ratio). The 30-35% trim captures meaningful profit protection without capitulating a confirmed uptrend — per the 8/11 EMR lesson, when structural floor contradicts near-term technical caution, weight the floor more heavily and trim less. Reject $168.50 buy-stop as chase behavior; replace with hard stop at $152.88. Do not pre-commit to re-entry zones — let Q4 FY26 print and pullback to 50 SMA ($145.22) guide re-engagement organically.
| Position | Action |
|---|---|
| Benchmark-weight accounts | Move to ~70% of benchmark weight |
| Overweight accounts | Trim to benchmark weight |
| Existing holders generally | Trim 30-35% at current $163-165 zone |
| Any position approaching $152.88 (breakout level) | Hard stop — structural invalidation point |
EMR is a quality industrial-software compounder at an inflection point, transitioning from traditional automation to AI-enabled data center solutions, with a decisive technical breakout, 58% embedded EPS growth, and the macro backdrop of a soft landing + stable rates + AI capex acceleration creating an asymmetric risk/reward setup.
| Indicator | Value | Signal |
|---|---|---|
| Price (Close) | $163.80 | bullish |
| 10 EMA | $157.85 | bullish |
| 50 SMA | $145.22 | bullish |
| 200 SMA | $140.12 | bullish |
| MACD Line | 5.59 | bullish |
| MACD Signal Line | 4.19 | bullish |
| MACD Histogram | +1.40 (expanding but decelerating) | neutral |
| RSI (14) | 68.38 | neutral |
| Bollinger Upper Band | $168.45 | bullish |
| Bollinger Middle Band (20 SMA) | $150.52 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price pullback toward $145.22
Then: Let pullback organically guide re-engagement rather than pre-committing
RSI at 68.4 is not overbought; momentum remains intact
↩ rebuts: “Bear's overbought/overextended warning”
EV: Upside to $168.45 (upper Bollinger Band) → $175+; Downside to $157.85 (10 EMA) or $152.88 = 3-7% pullback in intact uptrend · concedes: Bear's TTM P/E of 35.8x does look 'rich' on trailing basis; Today's close near low on lighter volume is a 'profit-taking bar'—a digestion day after the rally; Rate of MACD histogram expansion has moderated naturally after a sharp move; FY25 revenue growth of 3% is a real data point, though explained by AspenTech integration year
EMR's bull case is built on management guidance and optimistic consensus rather than reported fundamentals; at 36x trailing earnings with a stock extended 21% in three weeks on declining volume, the risk/reward asymmetry favors bears—the downside to the 50 SMA alone is 11.4% versus 6.8% upside to targets.
· concedes: Q3 FY26 was a beat on EPS consensus ($1.28 vs $1.12); Guidance was raised to $6.55 FY26 EPS; Business model is shifting toward higher-quality software revenue; FCF generation is strong; EMR is a quality company with a long-term thesis that has merit; Trend is intact for existing longs
→ vs neutral: The trend-is-strong momentum narrative is intellectually lazy; you trim into strength when the crowd is drunk on the narrative, not into weakness
→ vs conservative: The 22.7x multiple is anchored to consensus estimates above management's own raised FY26 guidance of $6.55, making it contingent on beats not yet achieved
→ vs conservative: Support at 50 SMA is not a reason to hold; the play is to take profits and re-enter at better levels, not to rely on support holding
| Bollinger Lower Band |
| $132.60 |
| bullish |
| VWMA (30-day) | $154.69 | neutral |
| ATR | $4.75 | neutral |
| Volume (Today) | ~1.99M shares | neutral |
Support: 164.38 · 158.84 · 157.85 · 152.88 · 150.52 · 145.22 · 140.12 | Resistance: 166.24 · 168.45
EMR shows a strong uptrend with price well above all major moving averages (10 EMA $157.85, 50 SMA $145.22, 200 SMA $140.12) and a golden cross intact from earlier in the year. The breakout above the $152.88 June high is confirmed by MACD (line 5.59 crossing above signal 4.19 around July 24-27), but momentum is showing early warning signs: MACD histogram is flattening, RSI at 68.4 is approaching overbought territory, and VWMA ($154.69) is lagging the 21% price rally with declining volume on the advance. Bollinger Bands are expanding with upper band at $168.45 acting as next resistance; a healthy pullback toward the $152.88-$157.85 zone would be normal and constructive. The recommendation is to HOLD existing longs with trailing stop near $156, BUY on pullback, and avoid chasing above $168.50 without volume confirmation.
Market Cap
$91.4B
Share Price
~$163
TTM P/E
35.84x
Forward P/E
22.65x
PEG Ratio
1.83
P/B
4.48x
EPS TTM
$4.57
Forward EPS
$7.23
Dividend Yield
1.35%
Beta
1.235
52-Week High
$166.24
52-Week Low
$122.64
50-Day Moving Avg
$144.77
200-Day Moving Avg
$140.60
Revenue FY2024
$17,492M
Revenue FY2025
$18,016M
Gross Profit FY2025
$9,519M
Operating Income FY2025
$3,532M
Net Income FY2025
$2,293M
Diluted EPS FY2025
$4.04
EBITDA FY2025
$4,839M
TTM Free Cash Flow
$3,706M
FCF Yield
~4.1%
Total Assets FY2025
$41,964M
Total Equity FY2025
$20,282M
Total Debt FY2025
$13,759M
Current Ratio
0.90
Goodwill & Intangibles FY2025
$27,651M
Net Tangible Assets
-$7,369M
Working Capital FY2025
-$1,214M
ROE TTM
12.8%
ROA TTM
6.9%
Gross Margin TTM
~53.2%
Operating Margin FY25 GAAP
19.6%
Profit Margin TTM
13.83%
Interest Coverage
~8.6x
Dividend Streak
67 years
Annual Dividend
$2.14/share
Acquisition Spending NI
~$8.3B
Acquisition Spending AspenTech
~$9.6B aggregate
Strengths
Concerns
Emerson Electric has completed a major portfolio transformation into an automation pure-play through $17B+ in acquisitions (NI ~$8.3B in FY2023; AspenTech ~$9.6B aggregate in FY2024), positioning itself in digital industrial automation and AI-driven process optimization. The company reported FY2025 revenue of $18,016M (+3.0%), operating margin of 19.6% (up from 15.2% trough in FY2024), net income of $2,293M, and diluted EPS of $4.04, with trailing FCF of $3.7B representing a structural improvement from the pre-transformation era. The stock trades at a premium (TTM P/E 35.84x, Forward P/E 22.65x) justified by software mix and ~58% expected FY26 EPS growth ($7.23 vs $4.57 TTM), supported by 67 years of consecutive dividend increases and capital returns of ~$2.4B annually via dividends and buybacks.
Macro: The macro backdrop is a "soft-landing + stable-rates" regime: prediction markets price an 86% probability of no Fed rate cuts in 2026 (down 2pp WoW), an 8% US recession risk (down 1pp WoW), and only a 6% chance of >5% inflation in 2026 (down 6.5pp WoW). Treasury yields are slipping on benign CPI/PCE data. Nasdaq is charging higher on the back of AI earnings strength, with CoreWeave soaring. This environment historically favors high-quality industrial automation equities with recurring software revenue and long-duration cash flows.